pillbase.ru

Filspari

Active substance: sparsentan

sparsentan

Centralised EU authorisationActive

Marketing holder: Vifor France

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • FILSPARI
    TABLET, FILM COATED · SPARSENTAN 400 mg/1
    68974-400
    Travere Therapeutics, Inc.
  • FILSPARI
    TABLET, FILM COATED · SPARSENTAN 200 mg/1
    68974-200
    Travere Therapeutics, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-aa34-772b-8797-3b4f6ac989b1,01a12094-84ce-7626-b7a5-f7b65c353385;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005783
Registration status
Active
ATC code
C09XX01
Sources
  • product · EMA · EMEA/H/C/005783 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005783 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005783 · Verified 2026-10-09